Linda Basse
Keine laufenden Positionen mehr
Profil
Linda Basse worked as a Medical Director at Genmab A, Topotarget A, and Zealand Pharma A.
She also served as the Chief Medical Officer at Medivir AB from 2018 to 2020.
Dr. Basse holds a doctorate degree from the University of Copenhagen.
Ehemalige bekannte Positionen von Linda Basse
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVIR AB | Chief Tech/Sci/R&D Officer | 30.09.2020 |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
| TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | - |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Linda Basse
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| MEDIVIR AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
